Miyai K
Department of Laboratory Medicine, Osaka University Medical School.
Rinsho Byori. 1991 Dec;39(12):1282-90.
Recent developments in molecular biology have brought dramatic changes in laboratory medicine. Applications of molecular biology techniques have made it possible to make etiological diagnosis and produce recombinant proteins for reagents. Laboratory investigations of molecular biology in the hypothalamic-pituitary-thyroid axis include TRH gene, TRH effect, TSH gene, TSH receptor and its autoantibodies, thyroid peroxidase and thyroglobulin and their autoantibodies, thyroxine (T4) binding protein genes, deiodination of T4, thyroid hormone receptor, oncogenes of thyroid etc. The following developments are reviewed. 1) Human TSH (hTSH) beta gene and its abnormality: Two types of mutations of hTSH beta gene have been found in patients with hereditary isolated TSH deficiency. DNA diagnosis and genetic counseling are now being performed. 2) Structure and function of TSH receptor: The primary structure of hTSH receptor was identified from its gene. Relationships between its structure and function have been investigated using site specific mutagenesis and synthetic short peptides. 3) Thyroid hormone receptor gene and its abnormality: The thyroid hormone receptor gene has been successfully cloned. Several mutations of the gene have been demonstrated in patients with thyroid hormone resistance. 4) Application of recombinant hTSH (r-hTSH):r-hTSH has been produced in CHO cells. Immunological and biological properties of r-hTSH are similar to those of authentic pituitary hTSH. Clinical application of r-hTSH is now in progress.
分子生物学的最新进展给检验医学带来了巨大变化。分子生物学技术的应用使得病因诊断以及生产用于试剂的重组蛋白成为可能。下丘脑 - 垂体 - 甲状腺轴的分子生物学实验室研究包括促甲状腺激素释放激素(TRH)基因、TRH 效应、促甲状腺激素(TSH)基因、TSH 受体及其自身抗体、甲状腺过氧化物酶和甲状腺球蛋白及其自身抗体、甲状腺素(T4)结合蛋白基因、T4 的脱碘作用、甲状腺激素受体、甲状腺癌基因等。以下是相关进展综述。1)人促甲状腺激素(hTSH)β基因及其异常:在遗传性孤立性促甲状腺激素缺乏患者中发现了两种 hTSH β基因突变类型。目前正在进行 DNA 诊断和遗传咨询。2)TSH 受体的结构与功能:从其基因中鉴定出了 hTSH 受体的一级结构。已使用位点特异性诱变和合成短肽研究了其结构与功能之间的关系。3)甲状腺激素受体基因及其异常:甲状腺激素受体基因已成功克隆。在甲状腺激素抵抗患者中已证实该基因存在多种突变。4)重组人促甲状腺激素(r - hTSH)的应用:r - hTSH 已在 CHO 细胞中生产。r - hTSH 的免疫学和生物学特性与天然垂体 hTSH 相似。r - hTSH 的临床应用正在进行中。